rs7097397

This is a protein-altering variant in the WDFY4 gene.

GWAS Catalog Trait Associations (5)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

systemic lupus erythematosus

Allele G
OR 0.81
p 2.0e-40
N 208,370
Meta-analysisLarge GWAS
East Asian
Allele G
OR 1.20
p 9.0e-12
N 14,267
Large GWAS
European
Allele G
OR 1.30
p 8.0e-12
N 1,798
Large GWAS
multi-ancestry

rheumatoid arthritis

Allele A
OR 0.92
p 1.0e-12
N 311,292
Meta-analysisLarge GWAS
multi-ancestry
Allele A
OR 0.93
p 1.0e-12
N 276,020
Large GWAS
multi-ancestry

primary biliary cirrhosis

Allele A
OR 0.14
p 2.0e-10
N 24,510
Meta-analysisLarge GWAS
European

Research that mentions this SNP (1)

Identification of a Systemic Lupus Erythematosus Risk Locus Spanning ATG16L2, FCHSD2, and P2RY2 in Koreans
AssociationN=5,422Christopher J. Lessard et al.(2016)· Arthritis &amp; Rheumatology

Genome-wide association study in 1,174 Korean SLE cases and 4,248 controls identified 12 genome-wide significant loci, including a novel locus spanning ATG16L2, FCHSD2, and P2RY2 peaking at rs11235667 (P=1.0×10⁻⁸, OR=0.59). The study replicated 10 previously established SLE risk loci (STAT4, TNFSF4, TNFAIP3, IKZF1, HIP1, IRF5, BLK, WDFY4, ETS1, IRAK1-MECP2) and identified novel independent effects in TNFAIP3 and TNFSF4. HLA-DRB1*1501 and HLA-DQB1*0602 were the strongest HLA associations (P=5.55×10⁻¹⁶, OR=1.85 and OR=1.90 respectively).

Traits studied:Systemic lupus erythematosus (SLE)

About WDFY4

Predicted to be involved in antigen processing and presentation. Predicted to act upstream of or within with a positive effect on CD8-positive, alpha-beta T cell activation. Predicted to act upstream of or within cellular response to virus. Predicted to be located in early endosome and endoplasmic reticulum. [provided by Alliance of Genome Resources, Jul 2025]

View all WDFY4 variants →

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…